![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 0114-9954
Source: Reactions Weekly, Vol.1, Iss.1346, 2011-01, pp. : 25-26
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Adalimumab: First report of meningoencephalitis in an elderly patient: case report
Reactions Weekly, Vol. 1, Iss. 1130, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Infliximab: Listeria meningoencephalitis: case report
Reactions Weekly, Vol. 1, Iss. 1198, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Infliximab: Fatal meningoencephalitis: case report
Reactions Weekly, Vol. 1, Iss. 1109, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Infliximab: Tuberculous meningoencephalitis: case report
Reactions Weekly, Vol. 1, Iss. 1338, 2011-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Albendazole/mebendazole: Drug hypersensitivity: case report
Reactions Weekly, Vol. 1, Iss. 1155, 2007-01 ,pp. :